12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | July 18, 2023 01:31pm

Gainers

• icad (NASDAQ:ICAD) shares moved upwards by 69.7% to $3.5 during Tuesday's regular session. The current volume of 28.3 million shares is 7661.0% of icad's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $88.9 million.
• Evelo Biosciences (NASDAQ:EVLO) shares moved upwards by 30.98% to $4.65. Trading volume for this security as of 13:30 EST is 2.8 million, which is 462.6% of its average full-day volume over the last 100 days. The company's market cap stands at $87.3 million.
• Biophytis (NASDAQ:BPTS) stock increased by 29.86% to $2.87. Trading volume for Biophytis's stock is 12.8 million as of 13:30 EST. This is 125890.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.9 million.
• Hyperfine (NASDAQ:HYPR) shares moved upwards by 29.48% to $3.03. Trading volume for this security as of 13:30 EST is 8.6 million, which is 2929.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $215.3 million.
• Marker Therapeutics (NASDAQ:MRKR) shares rose 16.3% to $5.89. Marker Therapeutics's stock is trading at a volume of 101.5K shares as of 13:30 EST. This is 11.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $51.7 million.
• Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock rose 15.61% to $0.66. Trading volume for this security as of 13:30 EST is 145.7K, which is 251.6% of its average full-day volume over the last 100 days. The company's market cap stands at $8.3 million.

Losers

• 9 Meters Biopharma (NASDAQ:NMTR) stock decreased by 68.0% to $0.2 during Tuesday's regular session. Trading volume for 9 Meters Biopharma's stock is 5.7 million as of 13:30 EST. This is 5542.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.8 million.
• Lixte Biotech Hldgs (NASDAQ:LIXT) shares decreased by 29.35% to $5.32. The current volume of 365.7K shares is 389.8% of Lixte Biotech Hldgs's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $8.8 million.
• Apellis Pharmaceuticals (NASDAQ:APLS) stock decreased by 26.5% to $38.56. As of 13:30 EST, Apellis Pharmaceuticals's stock is trading at a volume of 17.5 million, which is 946.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.4 billion.
• CEL-SCI (AMEX:CVM) shares declined by 23.78% to $2.18. Trading volume for this security as of 13:30 EST is 2.0 million, which is 1004.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $97.4 million.
• Acumen Pharmaceuticals (NASDAQ:ABOS) shares decreased by 23.34% to $7.45. Acumen Pharmaceuticals's stock is trading at a volume of 2.7 million shares as of 13:30 EST. This is 358.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $305.7 million.
• Aptevo Therapeutics (NASDAQ:APVO) shares decreased by 22.54% to $1.1. As of 13:30 EST, Aptevo Therapeutics's stock is trading at a volume of 2.7 million, which is 4632.8% of its average full-day volume over the last 100 days. The company's market cap stands at $8.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ABOS APLS APVO BPTS CVM CYCC EVLO HYPR ICAD LIXT MRKR NMTR